APA

O'Malley C. J., Rasko J. E., Basser R. L., McGrath K. M., Cebon J., Grigg A. P., Hopkins W., Cohen B., O'Byrne J., Green M. D., Fox R. M., Berndt M. C. & Begley C. G. (19961216). Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. : Blood.

Chicago

O'Malley C J, Rasko J E, Basser R L, McGrath K M, Cebon J, Grigg A P, Hopkins W, Cohen B, O'Byrne J, Green M D, Fox R M, Berndt M C and Begley C G. 19961216. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. : Blood.

Harvard

O'Malley C. J., Rasko J. E., Basser R. L., McGrath K. M., Cebon J., Grigg A. P., Hopkins W., Cohen B., O'Byrne J., Green M. D., Fox R. M., Berndt M. C. and Begley C. G. (19961216). Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. : Blood.

MLA

O'Malley C J, Rasko J E, Basser R L, McGrath K M, Cebon J, Grigg A P, Hopkins W, Cohen B, O'Byrne J, Green M D, Fox R M, Berndt M C and Begley C G. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. : Blood. 19961216.